keepMED

Company Overview

Snapshot

Founded in April 2012 by Alex Rapoport, keepMED is a medical technology company with 1–10 employees. The company has raised $25.63 million across 3 funding rounds from 9 investors. In March 2023, keepMED ceased to operate.

Business overview

keepMED is a medical technology company focused on developing treatment solutions for obstructive sleep apnea (OSA). Its core product, the keePAP device, is a hose-less, wearable, therapeutic positive airway pressure (PAP) system designed to restore normal breathing with minimal airflow. The company operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Digital Therapeutics, targeting patients globally, with a focus on markets in Israel and the United States.

Strategic signal

In March 2023, keepMED ceased to operate, indicating a significant operational closure for the company. This event signals to investors and innovation teams a complete halt in the company's trajectory and product development efforts, despite previous funding rounds aimed at advancing its keePAP device for obstructive sleep apnea.

Company Intelligence Q&A

What is keepMED's primary focus?

keepMED is a medical technology company dedicated to providing treatment solutions to improve the health and quality of life of people with obstructive sleep apnea.

What is the keePAP device?

The keePAP device is a hose-less, wearable, therapeutic positive airway pressure (PAP) on-demand device with minimal airflow, designed to gently and effectively restore normal breathing for individuals with obstructive sleep apnea.

When did keepMED cease operations?

keepMED ceased to operate in March 2023.

What was the company's last disclosed funding round?

In September 2020, keepMED raised a Series C round from investors including Merieux Equity Partners.

Which investors participated in the Series B funding round?

In April 2015, keepMED (then Ninox Medical) raised a Series B round with participation from.